Inactivation of the porB gene reduces the virulence of Neisseria meningitidis in transgenic mice
- PMID: 40818988
- PMCID: PMC12357335
- DOI: 10.1186/s12866-025-04246-3
Inactivation of the porB gene reduces the virulence of Neisseria meningitidis in transgenic mice
Abstract
Background: Neisseria meningitidis is a human pathogen, carried asymptomatically in the nasopharynx, that can also cause invasive meningococcal disease. Understanding the carriage/invasiveness balance is crucial, and bacterial genetic factors may impact this balance. A previous genome-wide association study reported that the gene porB class 3 was significantly associated with carriage isolates. This study aimed to examine the impact of porB variants on virulence in carriage and invasive meningococcal isolates.
Results: For this, 24 isolates were used (13 invasive and 11 carriage) belonging to different genogroups (B, C, W, Y, and cnl) and selected based on the presence of the genetic variant porB class 2 or class 3. Transgenic BALB/c mice expressing human transferrin were infected intraperitoneally with these isolates. After 3 and 24 h of infection, clinical scores (fur quality, strength, and temperature) and bacterial load in blood were used to evaluate bacterial virulence. The concentrations of inflammatory cytokines were determined from blood. PorB- mutants were created from a carriage and an invasive isolate, and were tested in transgenic mice. The invasive isolates provoked significantly more severe infections compared to the carriage isolates, and the carriage isolates of porB class 3 were significantly less virulent than the invasive isolates of porB class 2 or 3. The invasive PorB- isolate caused milder infections than the parental isolate.
Conclusions: This study confirms the ability of invasive isolates of N. meningitidis to cause more severe infections than carriage isolates in transgenic mice. The porB expressed in invasive isolates seems to contribute to their higher virulence compared to carriage isolates, although this effect may depend on the genomic context. Notably, differences in virulence were mainly observed among serogroup C and W isolates.
Keywords: Neisseria meningitidis; PorB; Carriage; Experimental infection; Inflammatory cytokines; Invasive meningococcal disease; Transgenic mice.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical permission for the meningococcal isolates collected during the carriage study [20] had previously been given by the regional ethical review board in Uppsala, Sweden (reference number 2017/499). The meningococcal isolates could not be linked to specific individuals. The study was carried out in strict accordance with the European Union Directive 2010/63/EU (and its revision 86/609/EEC) on the protection of animals used for scientific purposes and under the administrative authorization for animal experimentation (Permit Number 75-1554) and the approval of the Institut Pasteur Board (Dap210087/N°APAFIS #34085-2021112212171298 v1). The protocol was approved by the Institut Pasteur Review Board, which is part of the Regional Ethical Committee for Animal Experiments of the Paris Region (Protocol 23.133_AC456). The ARRIVE guidelines were adhered to in this study [38]. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures






Similar articles
-
Epidemiological characteristics of invasive meningococcal disease and carriage prevalence of Neisseria meningitidis in the Xinjiang Uygur Autonomous Region, China, 2004-2023: a retrospective study.PeerJ. 2025 Jul 29;13:e19772. doi: 10.7717/peerj.19772. eCollection 2025. PeerJ. 2025. PMID: 40755789 Free PMC article.
-
Pathogenicity of invasive and non-invasive CC4821 Neisseria meningitidis.BMC Microbiol. 2025 Aug 4;25(1):476. doi: 10.1186/s12866-025-04231-w. BMC Microbiol. 2025. PMID: 40760651 Free PMC article.
-
Prevalence, serogroup distribution and risk factors of Neisseria meningitidis carriage in high school and university students in Hungary.Vaccine. 2024 Apr 2;42(9):2271-2277. doi: 10.1016/j.vaccine.2024.02.064. Epub 2024 Feb 29. Vaccine. 2024. PMID: 38423809
-
Neisseria Meningitidis Carriage Among Hajj and Umrah Pilgrims: A Systematic Review and Meta-Analysis.Eur J Med Res. 2025 Aug 5;30(1):710. doi: 10.1186/s40001-025-02926-4. Eur J Med Res. 2025. PMID: 40765002 Free PMC article. Review.
-
Antibiotics for preventing meningococcal infections.Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004785. doi: 10.1002/14651858.CD004785.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2011 Aug 10;(8):CD004785. doi: 10.1002/14651858.CD004785.pub4. PMID: 17054214 Updated.
References
-
- Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med. 2001;344:1378–88. - PubMed
-
- Parikh SR, Campbell H, Bettinger JA, Harrison LH, Marshall HS, Martinon-Torres F, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020;81:483–98. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical